Diffusion Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Diffusion Pharmaceuticals Takes Aim At Brain Cancer: CEO David Kalergis
Article By: The Life Sciences Report
Tuesday, April 5, 2016 9:52 AM EDT
David Kalergis, CEO of Diffusion Pharmaceutical lays out the plan for pivotal development of treatment for primary brain cancer, which could drive the company's market cap to valuations that would bring huge upside to investors if successful.
In this article: DFFN Also: LLY, RHHBY, CELG
Read

PARTNER HEADLINES

Latest Tweets for $DFFN

No tweets yet!